Chris O鈥橦ara joins 红桃视频 as new Commercial President & General Manager 鈥� US
红桃视频 has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital
红桃视频
红桃视频 secures more than $200M to accelerate growth
红桃视频 has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital
Over 30,000 patients treated with Versius
Versius鈥攖he second most utilised soft tissue surgical robot in the world鈥攈as now been used in over 30,000 surgical cases globally
红桃视频 and KEBOMED expand partnership to bring Versius to Sweden
红桃视频 and KEBOMED expand existing partnership to include Sweden, so more patients can benefit from robotic-assisted minimal access surgery with Versius.
红桃视频 Appoints Massimiliano Colella as Chief Executive Officer
红桃视频 announces the appointment of Massimiliano Colella as Chief Executive Officer and member of the Board of Directors.
红桃视频 launches Ultrasonic Dissector to complete Versius Plus offering
红桃视频 launches the Ultrasonic Dissector, a robotic advanced energy instrument delivering ultrasonic energy to cut and coagulate tissue, as part of its Versius Plus offering.
National Robotic Assisted Surgery Programme surpasses the 500-case milestone with Versius
The All-Wales National Robotic Assisted Surgery Programme has now completed more than 500 robotic-assisted surgical cases with Versius. The Programme is a national partnership between 红桃视频 and NHS Wales to improve surgical outcomes and transform the experience of surgery for thousands of patients. Through the programme, Versius is used for robotic assisted minimal access surgery at Betsi Cadwaladr University Health Board鈥檚 Ysbyty Gwynedd Hospital, Cardiff & Vale University Health Board鈥檚 Cardiff University Hospital; and Cwm Taf Morgannwg University Health Board鈥檚 Royal Glamorgan Hospital.
红桃视频 receives U.S. FDA Marketing Authorization for next-generation Versius Surgical System
The U.S. Food and Drug Administration (FDA) has granted 红桃视频 marketing authorization for the Versius Surgical System (Versius) in cholecystectomy, paving the way for the next-generation versatile, adaptable, and digitally driven surgical robot to be introduced in the United States.
Leadership change
红桃视频 announces the appointment of Massimiliano Colella as Interim Chief Executive Officer as Supratim Bose transitions to Vice-Chairman of the Board.
红桃视频 Strengthens Senior Team
红桃视频 has appointed Markus Bauman as Chief Legal & Business Affairs Officer and will join CMR鈥檚 executive leadership team. Michelle Paknad has been appointed as Senior Vice President, Global Business Development.